Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Rose

Showing results (271-280 of 277) with videos related to

Pageof 28
Sort By:
You have reached the last page of results.This site can display upto 277 results.
Oncogene|February 3, 2022
HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotinMarco Biondini, Alex Kiepas, Leeanna El-Houjeiri, et al.
JCO Precision Oncology|August 17, 2022
Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant TumorsMatthew Dankner, Yifan Wang, Rouhi Fazelzad, et al.
Nature Communications|January 3, 2026
Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trialApril A N Rose, Jennifer Maxwell, Emmanuelle Rousselle, et al.
Nucleic Acids Research|December 6, 2014
BioAssay Research Database (BARD): chemical biology and probe-development enabled by structured metadata and result typesE A Howe, A de Souza, D L Lahr, et al.
Journal for Immunotherapy of Cancer|January 20, 2021
Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibitionAljosja Rogiers, Ines Pires da Silva, Chiara Tentori, et al.
Medrxiv : the Preprint Server for Health Sciences|August 20, 2025
Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapyJoan Miguel Romero, Jamie Magrill, Nikita Kalashnikov, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2025
Repertoire and clinical hierarchy of AR locus alterations in castration-resistant prostate cancerT Virtanen, E M Kwan, K Parekh, et al.
Pageof 28

Showing results (271-280 of 277) with videos related to

Sort By:
Pageof 28
You have reached the last page of results.This site can display upto 277 results.
Oncogene|February 3, 2022
HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotinMarco Biondini, Alex Kiepas, Leeanna El-Houjeiri, et al.
JCO Precision Oncology|August 17, 2022
Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant TumorsMatthew Dankner, Yifan Wang, Rouhi Fazelzad, et al.
Nature Communications|January 3, 2026
Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trialApril A N Rose, Jennifer Maxwell, Emmanuelle Rousselle, et al.
Nucleic Acids Research|December 6, 2014
BioAssay Research Database (BARD): chemical biology and probe-development enabled by structured metadata and result typesE A Howe, A de Souza, D L Lahr, et al.
Journal for Immunotherapy of Cancer|January 20, 2021
Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibitionAljosja Rogiers, Ines Pires da Silva, Chiara Tentori, et al.
Medrxiv : the Preprint Server for Health Sciences|August 20, 2025
Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapyJoan Miguel Romero, Jamie Magrill, Nikita Kalashnikov, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2025
Repertoire and clinical hierarchy of AR locus alterations in castration-resistant prostate cancerT Virtanen, E M Kwan, K Parekh, et al.
Pageof 28